Diabetes Medication Advising for Personalized Glucose Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Managing diabetes, particularly type 2 diabetes, is complex due to the variety of anti-diabetes medications (ADMs) available, each with different characteristics, requiring a system to advise and manage selection and administration to maintain glucose levels within target ranges.
Innovation Solution
A clinical support system that analyzes patient condition parameters, selects and manages personalized treatment regimens for anti-diabetes medications, incorporating real-time data from various devices, and provides advice on dosing and lifestyle adjustments to maintain glucose levels within target ranges.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If multiple anti-diabetes medications are used to treat different types of diabetes, then treatment effectiveness is improved, but treatment complexity increases
Solution Approach 1:
The system segments diabetes treatment into distinct modules for different diabetes types (type 1, type 2, gestational) and treatment approaches (medication selection, dosing calculation, lifestyle management). Each module can be independently configured and managed, allowing comprehensive treatment coverage while maintaining organizational simplicity through structured segmentation of treatment pathways.
Solution Approach 2:
The clinical support system provides universal functionality across multiple diabetes types and treatment scenarios. A single integrated platform handles medication selection, dosing calculations, glucose target setting, and lifestyle recommendations for various patient populations, eliminating the need for separate specialized systems and reducing overall treatment management complexity.
2Manufacturing precision
If personalized treatment regimens are developed considering multiple factors, then treatment precision is improved, but system complexity increases
Solution Approach 1:
The system applies local quality by tailoring treatment parameters specifically to each patient's characteristics. Glucose target ranges, medication dosages, and treatment recommendations are customized based on individual factors such as diabetes type, age, weight, renal function, and lifestyle. This localized personalization achieves high treatment precision without requiring complete system redesign for each patient.
Solution Approach 2:
The system dynamically adjusts treatment parameters based on patient responses and changing conditions. Glucose targets, medication dosages, and treatment frequencies are modified according to measured glucose levels, patient compliance, side effects, and evolving clinical status. This parameter adaptability enables continuous optimization of treatment precision while maintaining manageable system complexity through standardized adjustment protocols.
3Measurement precision
If real-time glucose monitoring is implemented, then glucose control accuracy is improved, but measurement and management difficulty increases
Solution Approach 1:
The system implements continuous feedback loops where real-time glucose measurements from monitoring devices are automatically transmitted to the clinical support platform. The system processes this data, compares it against target ranges, and provides immediate feedback through alerts, recommendations, and automated dosage adjustments. This feedback mechanism transforms complex real-time data into actionable insights, improving glucose control accuracy while reducing management burden.
Solution Approach 2:
The system enables self-service through automated glucose target calculation, medication dosing recommendations, and treatment adjustment based on monitored glucose levels. Patients and providers can access pre-configured algorithms that automatically process glucose data and generate personalized recommendations without requiring manual calculation or complex interpretation, thereby reducing management difficulty while maintaining high measurement precision.
Data Source
Figure 1A
Figure 1B
Figure 1C
AI summary
A method (900) includes obtaining prescribing drug information (196) and published guidelines (198) for each of a plurality of ADMs (810) available for managing glucose levels, and receiving patient information associated with a patient (10). The method also includes ordering total demerit values (812e) from lowest to highest, selecting a predetermined number of recommended ADMs associated with the lowest total demerit values, and determining a recommended dosage for each recommended ADM. The method also includes transmitting a therapy regimen to a patient device (110) associated with the patient. The therapy regimen includes the recommended ADMs and the recommended dosage for each recommended ADM.